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This review will consider the impact of compromised PTEN signaling in brain patterning.
We approach understanding the contribution of PTEN to nervous system development by
surveying the findings from the numerous genetic loss-of-function models that have been
generated as well as other forms of PTEN inactivation. By exploring the developmental
programs influenced by this central transduction molecule, we can begin to understand
the molecular mechanisms that shape the developing brain. A wealth of data indicates that
PTEN plays critical roles in a variety of stages during brain development. Many of them are
considered here including: stem cell proliferation, fate determination, polarity, migration,
process outgrowth, myelination and somatic hypertrophy. In many of these contexts, it
is clear that PTEN phosphatase activity contributes to the observed effects of genetic
deletion or depletion, however recent studies have also ascribed non-catalytic functions
to PTEN in regulating cell function. We also explore the potential impact this alternative
pool of PTEN may have on the developing brain. Together, these elements begin to form
a clearer picture of how PTEN contributes to the emergence of brain structure and binds
form and function in the nervous system.
Keywords: PTEN phosphohydrolase, brain development, mouse models, signal transduction, progenitor cells,
axon outgrowth
INTRODUCTION
Phosphatase and TENsin homolog (PTEN) is a protein/lipid
phosphatase that is responsible for regulating a myriad of sig-
nal transduction events in the brain including those essential
for central nervous system patterning. It is an ancient compo-
nent of many highly conserved signaling pathways includingmost
notably the Phosphatidyl Inositide 3-Kinase (PI3K)/mammalian
Target Of Rapamycin Complex 1 (mTORC1) pathway for which
PTEN serves as a major antagonist (Figure 1). This article will
explore the roles of this enzyme based on findings made primar-
ily using genetic loss-of-function studies within the developing
and adult nervous system and disciplines beyond where appro-
priate. Recent reviews have addressed the general cell biological
functions of PTEN as well as the regulatory mechanisms control-
ling its activity and expression (Song et al., 2012; Ortega-Molina
and Serrano, 2013). Many of its roles in mature nervous system
physiology and pathology are tackled by other articles within this
Research Topic. Here, we explore diverse aspects of brain devel-
opment influenced by PTEN including progenitor cell prolifera-
tion, cell fate determination, migration, polarity, axon-dendrite
morphogenesis, cell soma size, and myelination (Figure 2). The
observations discussed in this review reveal PTEN’s key roles in
cellular signaling that have the potential to be harnessed via cel-
lular, pharmacologic and genetic strategies to improve disease
outcomes (Yang et al., 2009; Ortega-Molina and Serrano, 2013;
Maire et al., 2014).
CELL PROLIFERATION/CELL FATE
The control of cell cycle timing and differentiation in the devel-
oping brain are essential elements for populating the nervous
system with the appropriate numbers and types of cells. Multiple
studies have demonstrated a key role for PTEN in stem cell main-
tenance and fate specification utilizing Cre recombinase mouse
strains to conditionally knockout (cKO) PTEN expression in var-
ious populations of cells in the embryonic retina and brain, early
post-natal, and adult brain regions including the cerebellum,
cortex, hippocampus. We have included an accompanying table
listing the Cre lines discussed in this review along with their pri-
mary reference and expression patterns (Table 1). Examination
of regulated loss-of-function models has resulted in many uni-
fying themes of PTEN function and observations that implicate
extra-cellular, trans-cellular or cell-type specific roles for PTEN.
While Cre recombinases offer a tremendous asset for understand-
ing tissue and cell-type specific gene function, it is important to
consider that recent work indicates that the timing of recombi-
nation may not correspond with the expected promoter-based
expression pattern (Liang et al., 2012; Harno et al., 2013).
DEVELOPING RETINA/OLFACTORY BULB
Conditional removal of PTEN expression in the developing
retina in Paired box 6 (Pax6)-Cre or CEH10 Homeodomain
Containing Homolog promoter-driven Cre (Chx10Cre) mice
results in alterations in progenitor maintenance and specifica-
tion/differentiation (Cantrup et al., 2012; Sakagami et al., 2012).
Pax-6-Cre-mediated deletion results in accelerated neurogenesis
and premature loss of retinal progenitor cells accompanied by tis-
sue hypertrophy not attributed to excessive stem cell production
(Cantrup et al., 2012). This is in contrast to observations from
other neuronal progenitor populations (see below) and illustrates
the importance of spatio-temporal context in determining the
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FIGURE 1 | Representative signal transduction pathways that have been found to either influencing or impacted by PTEN as described in the text.
FIGURE 2 | A summary of aspects of nervous system development altered by loss of PTEN expression during development or in post-natal ablation
studies as indicated by the text.
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Table 1 | Summary of Cre lines cited in this publication.
Cre line Publication cited
herein
Original
publication
Transgene
or knockin
Construct details Age: expression pattern
CamKII
alpha
Sperow et al.,
2012
Tsien et al., 1996 Transgene Alpha CamKII promoter-cre-pA;
11.1 kb
P18 - Adult: forebrain and
hippocampus—CA1/CA3 and some
dentate gyrus in hippocampus, some
cortex, and striatum
Chx10 Sakagami et al.,
2012
Rowan and Cepko,
2004
Targeted
knock-in
Chx10 promoter-GFPcreIRESAP-
FRT-Tn5/PGK
promoter-Neo/Kan-FRT
E11.5, P0: outer neuroblastic layer of
retina, nonpigmented prospective
ciliary body; high expression; P6:
ascending processes of bipolar cells;
P10: cell bodies and developing
dendrites of bipolar cells; P23: axons
and dendrites of bipolar cells; mostly
in inner nuclear layer
CNP1 Goebbels et al.,
2006
Lappe-Siefke
et al., 2003
Targeted
knock-in
Exon 1 of CNP gene:
ATG-Cre-PGK promoter-puromycin
Adult: cerebellar white matter; CNS
white matter tracts
DAT Inoue et al., 2013 Zhuang et al.,
2005
Targeted
knock-in
5′UTR of DAT-NLS-Cre-FRT-PGK
promoter-Neo-polyA-FRT; crossed
to FLP deleter line to remove PGK
cassette
Specificity confirmed to dopaminergic
neurons by tyrosine hydroxylase
staining; seen in VTA and SNc
DAT Diaz-Ruiz et al.,
2009
Backman et al.,
2006
Targeted
knock-in
IRES-NLS-Cre-FRT-PGK
promoter-Neo-polyA-FRT-3′UTR of
DAT locus; crossed to FLP deleter
line to remove PGK cassette
E15, E17, P0: VTA, substantia nigra,
retrorubral field; low expression in
glomeruli of olfactory bulb
Emx1 Lehtinen et al.,
2011
Gorski et al., 2002 Targeted
knock-in
IRES-Cre-intron/PolyA-PGK
promoter-neo—3′UTR of emx1
E10.5: shows dorsal telencephalon as
well as cranial nerve expression;
E12.5: shows dorsal pallium and
lateral pallium expression; Adult
brain: mitral and deep periglomerular
olfactory bulb, cingulate, cortex,
hippocampus, endopiriform nucleus
(ventral and dorsal), amygdaloid
nucleus, nucleus of lateral olfactory
tract, nuc of accessory olfactory tract,
amygdalohippocampal area,
basolateral amygdala, corpus
callosum, anterior commisure,
basomedial amygdala, posteromedial
amygdaloid nucleus; Summary:
progenitors and projection neurons
and Cajal Retzius cells and
oligodendrocytess from pallium as
well as astrocytes express emx1 but
inhibitory interneurons do not
En2
(Engrailed 2)
Marino et al., 2002 Zinyk et al., 1998 Transgene En2 enhancer-En2minimal
promoter fragment-Cre cDNA
Embryonic dorsal mid-hindbrain
junction starting as early as E9.5 and
staying consistent at E14.5 and adult
GFAP Kwon et al., 2001;
Chalhoub et al.,
2006
Kwon et al., 2001 Targeted
knock-in
Disruption of GFAP exon1 by Cre
insertion
Postnatal onset: Granule cells of
cerebellum and dentate gyrus; very
low expression in astrocytes and
pyramidal cells
hGFAP Fraser et al., 2004,
2008; Chalhoub
et al., 2009
Bajenaru et al.,
2002
Transgene hGFAP
promoter-Cre-IRES-Nuclear LacZ;
8 kb construct
E11.5–E14.5: brain first then spinal
cord and optic nerves; E18.5: brain,
optic nerves, and spinal cord;
(Continued)
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Table 1 | Continued
Cre line Publication cited
herein
Original
publication
Transgene
or knockin
Construct details Age: expression pattern
P7: astrocytes of hippocampus,
cerebellum, ventral forebrain, and in
Bergmann glia in cerebellum
hGFAP Yue et al., 2005;
Wen et al., 2013
Zhuo et al., 2001 Transgene 5′ flanking region of hGFAP
promoter-nuclear Cre-mous
protamine gene intron and polyA;
2.2 kb construct
E13.5: dorsal and medial
telencephalon, with full neuraxis
expression by birth; 5 weeks: high
expression in cortex, hippocampus,
cerebellum, low expression in
midbrain; also low expression in liver
(ductal cells); expression in Bergmann
glia of cerebellum as well as in
granule layer
mGFAP Gregorian et al.,
2009
Gregorian et al.,
2009
Transgene Full murine GFAP gene
sequence-Cre; 15 kb construct
Adult neural stem/progenitor
cells—seen in supependymal zone
(SEZ), rostral migratory stream,
olfactory bulb; cre-expressing cells
have nestin and GFAP staining in SEZ
L7 Marino et al., 2002 Oberdick et al.,
1990
Transgene Full L7 gene with LacZ cDNA in
4th exon
Purkinje cells in the cerebellum;
bipolar neurons in retina; low
expression in interpeduncular nucleus
Nestin Groszer et al.,
2001
Zimmerman et al.,
1994; Bates et al.,
1999
Transgene Rat nestin promoter-intron 2
enhancer-Cre
Expression beginning at 18 somite
stage; E9.5: ventral neural tube, and
spinal cord; E10.5 most of CNS;
E12.5: in brain and spinal cord; some
expression in heart and lungs, skin,
limbs adult: also some in salivary
gland, kidney, olfactory bulb; E18.5 -
expressed in progenitors of brain
Nestin
Cre-ERT2
Bonaguidi et al.,
2011; Zhu et al.,
2012
Balordi and Fishell,
2007
Transgene Rat nestin promoter-intron 2
enhancer-tk promoter-Cre
ERT2-SV40 PolyA
Typical nestin expression
pattern—E14.5: neural progenitors;
P60: very low spontaneous
recombination—only in presence of
tamoxifen does expression increase
substantially; expression patterns as
reported for nestin-cre in embryo and
adult, and last up to 2 month after
tamoxifen pulse
Nestin
Cre-ERT2
Amiri et al., 2012 Li et al., 2008b Transgene Rat nestin promoter/enhancer-Cre
ERT2 fusion protein cDNA-inverse
Nestn 2nd intron
Expression in previously reported (see
above) nestin patterns only after
tamoxifen induction, with some
background in thalamus
Nex Kazdoba et al.,
2012
Goebbels et al.,
2006
Targeted
knock-in
Nex coding region of exon2
replaced by Cre-sense oriented
NeoR-end of exon 2
Only in pyramidal cells of cortex, E12,
E13.5, E16.5: expressed in
differentiating cells but not
progenitors; Adult: in cortex and
hippocampus, dorsal horn of spinal
cord, periglomerular layer of olfactory
bulb, mitral layer of olfactory bulb,
habenular nuclei, amygdaloid nuclei,
piriform cortex, external cuneate
nucleus, lateralreticular nucleus,
nucleus of solitary tract, spinal
(Continued)
Frontiers in Molecular Neuroscience www.frontiersin.org May 2014 | Volume 7 | Article 35 | 4
Veleva-Rotse and Barnes PTEN in brain development
Table 1 | Continued
Cre line Publication cited
herein
Original
publication
Transgene
or knockin
Construct details Age: expression pattern
trigeminal nucleus; only seen in
neurons in vivo and vitro; marks
glutamatergic neurons in cortex, no
interneurons
Nse Kwon et al.,
2006a,b; Zhou
et al., 2009
Kwon et al., 2006b Transgene Nse promoter-NLS-Cre-SV40
PolyA; 3.5 kB construct
Layers 3–5 of cortex; CA3, dentate
gyrus, polymorphic layer and outer
granular layer of hippocampus; E13.5:
spinal cord and PNS during
development; P0: spinal cord, DRG,
trigeminal ganglia; 4 weeks: kidney
and testes and stomach; in neurons
but not glia; ∼55% of cortex, ∼40%
CA3, ∼50% dg, ∼60% PML
Olig2 Harrington et al.,
2010; Maire et al.,
2014
Schuller et al.,
2008
Targeted
knock-in
TVA-IRES-Cre-NeoR-Olig2 P7: 98% of white matter cells express
it; small subpopulation of CGNP’s in
EGL (cerebellar lobes 9 and 10); P21:
fate mapping to GC’s in IGL; few rRL
cells can generate Pax6+ CGNPs of
EGL and GC’s in IGL; rostral rhombic
lip progenitors, oligodendrocyte
precursor cells, NG2 cells,
interneurons
Pax6 alpha Cantrup et al.,
2012; Jo et al.,
2012
Marquardt et al.,
2001
Transgene Alpha-P0 promoter-Cre-IRES-GFP-
intron-polyA;
5.5 kb
E10.5: onset of expression in neural
retina, granule cell layer, inner nuclear
layer, outer nuclear layer
Plp1-ERT2 Goebbels et al.,
2010; Snaidero
et al., 2014
Leone et al., 2003 Transgene 15 kb of PLP gene regulatory
region-Cre-ERT2
8 weeks: Schwann cells, major white
matter structures in CNS only after
Tamoxifen treatment
Abbreviations: CGNP, cerebellar granule neuron precursor; CNS, central nervous system; DRG, dorsal root ganglia; EGL, external granular layer; ERT2, estrogen
receptor regulated by tamoxifen; GC, granule cell; IGL, inner granular layer; IRES, internal ribosomal entry site; LacZ, Beta galactosidase; NeoR, neomycin resistance;
NG2, NG2 proteoglycan +; NLS, nuclear localization signal; PGK, mouse phosphoglycerate kinase 1; PNS, peripheral nervous system; PolyA, polyadenylation signal;
SNc, substantia nigra pars compacta; TVA, avian tumor virus receptor A; VTA, ventral tegmental area.
cellular consequence to PTEN loss. Interestingly, recent evidence
also from the developing retina indicates that PTEN is nec-
essary in Notch-coordinated neurogenesis by downregulating
Akt/protein kinase B signaling and allowing the intracellular
domain of Notch to form a transcriptionally active complex in the
nucleus (Jo et al., 2012). In contrast, increased PTEN expression
in the developing retina ofmice lacking the transcriptional repres-
sive orphan nuclear receptor TLX/NR2E1 has been proposed
to contribute to decreased proliferation and increased apopto-
sis (Zhang et al., 2006). Similar progenitor cell alterations in the
cerebral cortex of TLX-null mice are thought to be due to parallel
perturbations in PTEN signaling as well as in expression of cyclins
and cyclin regulatory proteins (Li et al., 2008a). Given the broad
scope of genomic loci potentially targeted by the TLX repres-
sor complex, more work remains to resolve the relationships
between the phenotypes such as altered cell proliferation and
apoptosis observed following loss of either PTEN or TLX/NR2E1.
Olfactory bulb (OB) progenitor cells exhibit both similar and
distinct responses to PTEN modulation. In this case, expression
of a catalytically inactive form of PTEN led to increased differ-
entiation, and over-expression of PTEN in OB progenitors was
observed to inhibit differentiation without affecting cell survival
or proliferation (Otaegi et al., 2006). Treatment with insulin-like
growth factor 1 (IGF1) was able to overcome this suppression,
reinforcing the importance of extra-cellular influences on PTEN’s
impact on transduction. This effect of insulin-like growth fac-
tor on progenitor proliferation is reinforced by a recent study
exploring the genetic interaction of the apical complex protein
Pals1 and PTEN (Lehtinen et al., 2011). This study showed that
PTEN enhances signaling of insulin-like growth factors present
within cerebrospinal fluid through regulation of the IGF1 recep-
tor expression.
EMBRYONIC NEURAL STEM CELLS
Embryonic studies using various Cre recombinase deletion lines
share the common feature that elimination of PTEN expres-
sion results in alterations in stem cell niche maintenance and
proliferation (Backman et al., 2001; Groszer et al., 2001; Kwon
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et al., 2001; Fraser et al., 2004; Kwon et al., 2006a; Fraser et al.,
2008; Gregorian et al., 2009). Similar observations have been
made regarding adult neurogenesis in the hippocampus and sub-
ependymal zone (SEZ)/sub-ventricular zone (SVZ) (Bonaguidi
et al., 2011; Amiri et al., 2012; Zhu et al., 2012). The obser-
vations that PTEN loss accelerates G1/S transition (Sun et al.,
1999) and promotes G0 exit into the cell cycle (Groszer et al.,
2006) provide an excellent backdrop to consider the effects of
PTEN deletion in neural progenitors. Given the early lethal-
ity of whole-body PTEN deletion, Nestin-Cre provided one
of the first avenues into how neural progenitors respond to
loss of this key regulatory molecule (Groszer et al., 2001). An
increase in Bromodeoxyuridine (BrdU)-labeled cells in the telen-
cephalic ventricular zone coupled with reduced TUNEL staining
indicated a derangement in the normal balance of neural pro-
genitors. Embryonic day 14.5 neurosphere cultures from PTEN
mutant mice displayed an increase in proliferative capacity com-
pared to controls. Postnatal analysis of mice expressing a version
of glial fibrillary acidic protein (GFAP) promoter-directed Cre
did not detect significant alterations in cell proliferation, but
observed other phenotypes including seizures, ataxia, and macro-
cephaly (Backman et al., 2001; Kwon et al., 2001). Prenatal
loss of PTEN, mediated by Human GFAP (hGFAP) promoter-
regulated Cre, results in a significant increase in the number
of astrocytes following deletion (Fraser et al., 2008). This dif-
ference in the effect of PTEN loss highlights cell-type specific
responses and sensitivity to the timing of the Cre recombi-
nation deletion during development. Cre recombinase regu-
lated by the dorsal telencephalon-restricted transcription factor
Emx1 promoter also reveals an expanded progenitor prolifer-
ation following embryonic deletion of PTEN (Lehtinen et al.,
2011).
Conditional cerebellar PTEN deletion using Engrailed 2
(En2)-Cre revealed decreased proliferation and cell death
(Marino et al., 2002). Premature differentiation of Bergmann
glia has been detected by studies focused on the cerebellum of
floxed PTEN mice either using hGFAP-Cre, or mice injected with
virally encoded Cre (Yue et al., 2005). Together, these studies place
PTEN as a modulator of proliferative/apoptotic balance during
embryonic brain development.
ADULT NEURAL STEM CELLS
Adult neurogenesis is believed to represent a continuation or reca-
pitulation of embryonic programs in privileged cellular niches,
namely the subgranular zone of the dentate gyrus and SEZ/SVZ.
The role of PTEN in this progenitor population has been pur-
sued using four distinct Cre mouse lines, including a third version
of GFAP driven Cre (mGFAP) with expression limited to post-
natal progenitors (Gregorian et al., 2009). The mGFAP line was
used to delete PTEN and determine the effect in SEZ progeni-
tors. Neurospheres derived from these animals demonstrated an
enhanced ability for self-renewal (Gregorian et al., 2009), a result
paralleling previous observations in neurospheres derived from
embryonic tissue (Groszer et al., 2001, 2006).
The effect of PTEN loss in the SEZ/SVZ progenitors
has also been explored using three estrogen receptor T2
(tamoxifen-inducible) Cre (ERT2-Cre) lines controlled by the
Nestin promoter (Nestin-ERT2) (Bonaguidi et al., 2011; Amiri
et al., 2012; Zhu et al., 2012) but no significant difference in
proliferating progenitors of the SVZ was found (Zhu et al.,
2012). However, an expanded SEZ/SVZ and rostral migratory
stream (RMS) of cells migrating to the OBs was noted, similar
to that observed using mGFAP-Cre (Gregorian et al., 2009) or
Olig2Cre (Maire et al., 2014) deletion of PTEN, both of which
eliminate PTEN in the SVZ. The expansion in the case of the
Nestin-ERT2 animals was found to be due, in part, to ectopically
differentiated neurons in both locations as opposed to the typical
neuroblasts found in these regions, consistent with perturbed dif-
ferentiation following PTEN ablation. The SVZ expansion in this
particular model was also shown to be dependent on mTORC1
signaling as rapamycin treatment was able to prevent it (Zhu
et al., 2012). A role for PTEN in the adult neurogenic niche
of the dentate gyrus where stem cells exist at various stages
of lineage from neural stem cells to intermediate progenitors
and finally nascent neuroblasts has also been explored using cre
mouse strains. This cell population was also targeted by using
Nestin-ERT2 Cre in which either single clonal cells (Bonaguidi
et al., 2011) or ensembles of cells (Amiri et al., 2012) were
analyzed. Bonaguidi et al. employed the Mosaic Analysis with
Double Markers (MADM) to sparsely label progenitor cells and
their progeny via Cre recombination of split fluorescent protein
reporters (Zong et al., 2005). This approach permitted lineage
tracing from particular progenitors to detect proliferation and
differentiation of individual clonal populations. Three distinct
observations were made from these clones one month after label-
ing and deletion of PTEN: (1) There was a reduction in quiescent
progenitors, (2) clones had predominately undergone symmetric
division-based stem cell expansion and (3) clones had depleted
their progenitors and consisted of astrocytes, cells transitioning
into astrocytes, or neurons (Bonaguidi et al., 2011). The majority
of clones fell into the last category, indicating a failure to maintain
stem cell identity by those progenitors that lacked PTEN expres-
sion. This parallels the findings of Amiri et al. that neurospheres
derived from PTEN-null progenitors had an increased propensity
to undergo differentiation following growth factor withdrawal
(Amiri et al., 2012). Similarly, using BrdU to fate map the progeny
following acute deletion of PTEN, it was revealed that progeni-
tor depletion followed an early surge of neuro/glio-genesis, with
a bias toward astrocyte generation similar to that observed by
Bonaguidi et al.
The results discussed above indicate the importance of PTEN
expression and emerging data from microRNA studies indi-
cate that cells have mechanisms to post-transcriptionally reg-
ulate PTEN levels. Recent evidence implicating the miR-17-
92 microRNA cluster in regulating neural progenitor expan-
sion and differentiation also demonstrates that targeting PTEN
expression is one mechanism involved via miR-19, a microRNA
encoded within the miR-17-92 cluster (Figure 1) (Bian et al.,
2013). Interestingly, an additional level of regulation may exist
for PTEN based on the discovery that a processed pseudogene
RNA, PTENP1, can act as a microRNA decoy or competing
endogenous RNA (ceRNA) (Figure 1)(Salmena et al., 2011) to
negate or modulate the effect of microRNAs on PTEN expres-
sion (Poliseno et al., 2010). Future studies will be required to
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define the developmental, cell-type and species-specific expres-
sion patterns for this pseudogene in the nervous system, as
one study found that mice lack PTEN pseudogenes (Kwabi-
Addo et al., 2000). Similarly, the transcriptional co-activator
Yes-associated protein (YAP) has been shown to negatively reg-
ulate PTEN levels by controlling microRNA miR-29a transcrip-
tion (Figure 1) (Tumaneng et al., 2012). Remarkably, over-
expression of YAP and its co-activator TEAD, through up-
regulation of cell cycle genes such as Cyclin D1 increases neural
progenitor proliferation (Lavado et al., 2013). However, Cyclin
D1 expression does not appear to account for the effect of
YAP/TEAD. It is possible that miR-29a may mediate these effects
by lowering PTEN levels, contributing to increased progeni-
tor proliferation. Telencephalic deletion of the tumor suppres-
sor Neurofibromatosis 2 (NF2)/Merlin increases transcription
of YAP/TEAD targets (Figure 1), resulting in increased progen-
itor proliferation in the cortex and hippocampus (Lavado et al.,
2013) similar to that seen in PTEN loss. This observation rep-
resents a tantalizing link between PTEN and NF2, two proteins
previously described as tumor suppressors. These data regarding
microRNAs, along with a wealth of data demonstrating that
PTEN is regulated at both transcriptional and post-translation
levels (Song et al., 2012; Ortega-Molina and Serrano, 2013), indi-
cate the tremendous amount of cellular resources dedicated to
regulating PTEN expression, localization and enzymatic activ-
ity. It is unknown what portion of the cell cycle/differentiation
alterations following deletion of PTEN in the nervous sys-
tem are the result of disregulated signal transduction related
to the PI3K/mTORC1 pathway. Recent discoveries offer the
possibility that additional, non-phosphatase dependent modes
of action may exist for PTEN in the nucleus contributing to
cell fate.
An emerging aspect of PTEN regulation of cell fate arises from
the nuclear pool of PTEN first observed by Lachyankar et al. in
nerve growth factor-treated PC12 cells and brain-derived neu-
rotrophic factor-treated neurospheres (Lachyankar et al., 2000),
and since that time a neuronal role for this component of PTEN
has been sought. One function for nuclear PTEN is the regula-
tion of the Anaphase-Promoting Complex (APC)/CDH1 complex
through a protein-protein interaction yet independent of PTEN’s
phosphatase activity (Figure 1) (Song et al., 2011). Importantly,
APC/Cdh1 has been previously shown to transcriptionally regu-
late genes associated with neuronal differentiation (De La Torre-
Ubieta and Bonni, 2011). The nucleo-cytoplasmic shuttling of
PTEN is regulated by the deubiquitinating enzyme HAUSP/USP7
(Figure 1), and cKO of HAUSP in the brain demonstrated pro-
found phenotypes that may involve the loss of cytoplasmic PTEN
(Kon et al., 2011). This possibility awaits further experiments as
Kon et al. focused on the role of HAUSP regulation of p53. Their
results indicated that p53 loss did not completely rescue the loss
of HAUSP, leaving open a role for PTEN in HAUSP-cKO mice.
A nuclear function for PTEN presents an intriguing link between
the observed progenitor cell phenotypes in models of PTEN loss.
This includes the observation that PTEN over-expression inhibits
the induction of gene expression profiles consistent with neu-
ronal differentiation in PC12 cells and that the effect is not due
exclusively to perturbing growth factor signal, as PI3K andMAPK
inhibitors were insufficient to replicate this effect (Musatov et al.,
2004). This may indicate that excess PTEN protein may have
sequestered crucial nuclear co-factors such as APC/CDH1 from
their appropriate cellular locations and targets.
One of the mechanisms for PTEN nuclear import is through
the action of the Nedd4 family-interacting protein 1 (Ndfip1)
(Figure 1) (Hammond et al., 2013), a protein that has been
shown to regulate PTEN in part through controlling ubiqui-
tination, and by regulating PTEN secretion (Putz et al., 2012;
Hopkins et al., 2013). This pool of extracellular and potentially
trans-cellular PTEN offers attractive and yet-to-be-tested possi-
bilities regarding non-cell autonomous roles for PTEN signal-
ing during brain development. Interestingly, Ndfip1 is expressed
in the developing brain, and conditional deletion of Ndfip1
in embryonic cerebral cortex using Emx1Cre results in alter-
ations of neuronal morphology, but does not impact neuronal
number or specification (Goh et al., 2013; Hammond et al.,
2013). While this work did not directly explore the impact of
Ndfip1 loss on the subcellular distribution of PTEN, it did show
that total PTEN levels appeared unchanged. However, studies
of PTEN redistribution to the nucleus following ischemia find
that Ndfip1-deficient animals do not import PTEN following
anoxic injury, and that over-expression of Ndfip1 increased PTEN
import into the nucleus (Howitt et al., 2012). Additional studies
will be required to determine which of the observed pheno-
types in the Ndfip1 null brain may be attributable to a lack
of nuclear PTEN or perhaps other Ndfip1 targets. It is impor-
tant to note that neither the nuclear nor cytoplasmic pool of
PTEN alone can explain the observed deficits in the animal mod-
els we have discussed, but rather it is the concerted efforts of
both pools of PTEN that orchestrate appropriate nervous system
development.
CELL MIGRATION
The appropriate localization and distribution of stem cell progeny
make cell migration a key event in proper brain formation.
Given the central role of PTEN in the transduction of many
pathways that shape cellular responses to chemo-attractant or
-repellent cues, it would be reasonable to expect that certain
aspects of cell migration would be perturbed following the loss
of PTEN. Many studies of the developing brain find little indica-
tion of massive alterations in migration, but lamination defects
have been observed following Nestin-Cre deletion (Groszer et al.,
2001). However, it is unclear if this observation reflects defects in
migration or in progenitor proliferation.
Neuronal helix-loop-helix protein-1 (Nex1)Cre (Table 1) dele-
tion of PTEN only targets neurons that have left the cell cycle and
become fated as neurons. Immunohistochemical staining for lam-
inationmarkers such as Tbr1 (early born neurons) indicated a less
compact cerebral cortex with some Tbr1+ cells near the marginal
zone, and labeling of later born neurons using BrdU birthdating
or Cux1 staining appeared to have normal placement, indicat-
ing no major defect in migration or positioning (Kazdoba et al.,
2012). Somewhat surprisingly, these mice did display an increased
expression of Reelin, a secreted regulator of migration, relative
to controls. It is possible that the lack of effect on migration
could be due to inefficient NEX1Cre-mediated deletion of PTEN
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in these cells. Additional analyses of cortical structure using Cre
recombinases that target earlier steps in neurogenesis (Emx1Cre
and hGFAP-Cre) do find significant alterations in cortical orga-
nization and hippocampal radial glial persistence, respectively
(Lehtinen et al., 2011; Wen et al., 2013).
As described above, PTEN-null cells migrating from the
SVZ/SEZ along the RMS have been observed to fall into two
subsets of cells—those that prematurely differentiate within the
SVZ/SEZ, and those that continue to migrate to the OB (Zhu
et al., 2012). Live imaging studies of this second group of cells
indicated that their migratory speed was not statistically distin-
guishable from wild-type cells. The identity of the factors that
distinguish these two classes of migrating cells may hold a wealth
of information regarding chemotactic strategies employed by
various RMS-transiting neuroblasts.
Early studies of conditional PTEN loss in the brain detected
migration defects in the granule cells of the cerebellum (Backman
et al., 2001; Kwon et al., 2001). Interestingly, while deletion of
the Akt-activating kinase, Phosphoinositide-dependent kinase-1
(Pdk1), reverses some phenotypes observed in GFAPCre/PTEN
cKO mice (see Somal Hypertrophy below), it does not rescue
cerebellar granule cell migration defects (Chalhoub et al., 2009).
Experiments using L7/PCP2-cre to target PTEN deletion in
Purkinje cells of the cerebellum did not detect a major alteration
in cell placement, but ablation of PTEN by En2-Cre resulted in
a significant alteration in organization involving essentially all
constituent cells of the cerebellum (Marino et al., 2002). Later
work using hGFAP-Cre and viral delivery of Cre suggested that
the migration defect observed for granule cells is the result of
premature differentiation of Bergmann glia rather than a cell
autonomous effect (Yue et al., 2005). Taken together, these results
highlight the intrinsic diversity related to cell migration cues, cel-
lular responses and the multivalent ways in which PTEN may
shape them.
CELL POLARITY
PTEN plays a role in acquisition of polarity by augmenting
signal transduction from extracellular cues. Much of the work
exploring the role of PTEN in polarity and axon outgrowth has
focused on its phosphatase activity during membrane receptor
signaling. Experiments specifically exploring the ability of PTEN
to alter axon specification place it as a key element of axo-
genesis. Over-expression of PTEN results in a failure of axon
formation and neurite outgrowth (Shi et al., 2003; Jiang et al.,
2005). Conversely, RNA interference (RNAi) blockade of PTEN
expression leads to the formation of multiple axon projections
(Jiang et al., 2005). Caenorhabditis elegans PTEN ortholog daf-
18 mutant neurons fail to properly polarize and extend axons
(Adler et al., 2006), demonstrating the high degree of conserva-
tion across species. Additionally, in vivo loss-of-function studies
using Neural Specific Enolase (NSE)-Cre to generate cKO PTEN
mice indicate exuberant axon projections in the dentate gyrus
(Kwon et al., 2006a). It will be important in future studies to
assess whether these axonal defects are due to axon mis-targeting
or altered neuronal polarity, but it is clear that axonal develop-
ment is significantly altered following PTEN ablation in many
types of neurons. While these studies make a compelling case for
PTEN requirement during axon formation, these results do not
delineate a specific role for PTEN in the early asymmetry events
in axon specification or a role in regulation of axon outgrowth.
Clarity for this morphologic aspect of PTEN function will await
further investigation and new tools to probe the earliest events in
neuronal polarization.
AXON/DENDRITE OUTGROWTH
Beyond affecting early neurite specification, PTEN loss has been
associated with alterations in both axonal and dendritic struc-
ture. The nuclear pool of PTEN may contribute to this process as
well through its interaction with APC/CDH1. This complex has
been shown to regulate axon formation and outgrowth by tar-
geting transcriptional components for degradation. As described
earlier, PTEN could be contributing to the timing of axon specifi-
cation/outgrowth by increasing the association of APC andCDH1
(Lasorella et al., 2006; Stegmuller et al., 2006). The related com-
plex of APC/CDC20 has been implicated in axonal outgrowth (De
La Torre-Ubieta and Bonni, 2011), but whether PTEN associates
with this complex as well remains to be determined. PTEN/daf-18
has also been shown in multiple species to be crucial for shaping
of neuronal morphology by regulating the transcription factor
FoxO/daf-16 (Christensen et al., 2011) and by controlling the
PI3K-Akt signaling pathway.
Axon projections were more exuberant in both dopamine
transport promoter (DATCre) (Diaz-Ruiz et al., 2009; Domanskyi
et al., 2011; Inoue et al., 2013) and Nse-Cre (Kwon et al., 2006a)
deleted PTEN mouse lines. Adult newborn neurons respond to
PTEN depletion much like embryonic cells, as retroviral siRNA
in vivo increased axon diameter and bouton size (Luikart et al.,
2011). However, midbrain dopaminergic neurons targeted for
PTEN deletion using DATCre did not display an increase in ter-
minal bouton size (Diaz-Ruiz et al., 2009; Inoue et al., 2013).
In contrast, PTEN deletion using Ca2+/Calmodulin-dependent
protein kinase 2 promoter-driven (CaMKIIα)-Cre in mature neu-
rons of the forebrain resulted in altered morphologies of neuronal
processes (Sperow et al., 2012).
Work in Xenopus spinal neurons using pharmacologic inhibi-
tion of PTEN by Bisperoxo (1, 10-phenanthroline) oxovanadate,
morpholino knock-down, or catalytically-inactive PTEN over-
expression enhances axon growth when encountering target mus-
cle tissue (Li and Peng, 2012). This suggests a role for PTEN in
target recognition or down-regulation of axon growth signaling.
Furthermore, spinal neuron growth cone chemotaxis has been
shown to utilize PTEN selectively in response to chemorepul-
sive cues, demonstrating a potential context-dependent difference
in PTEN modulated responses (Henle et al., 2013). Loss of the
spinal motor neuron 1 gene (SMN1) leads to spinal motor atro-
phy and the axon outgrowth and growth cone defects associated
with the loss of the SMN1 gene expression can be rescued by
siRNA knockdown of PTEN (Ning et al., 2010). As the SMN1
protein plays a role in both small nuclear ribonucleic particle reg-
ulation and axonal RNA transport, this result may indicate that
PTEN contributes to the regulation of SMN1-regulated transla-
tion for axonal RNA through regulation of mTOR signaling, or
that the local translation of PTEN itself may be increased fol-
lowing the loss of SMN1, or both. During axon growth, PTEN
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may be the target of mRNA stability/translational regulation via
the microRNA cluster 17-92 member miR19 (Figure 1) (Zhang
et al., 2013), as described above in the regulation of neural stem
cells.
Experiments directed at understanding the ubiquitin protea-
some system in neurons led to the finding that the ubiquitin ligase
NEDD4 is capable of targeting PTEN for degradation (Figure 1)
(Drinjakovic et al., 2010). This work also demonstrated that
PTEN degradation is crucial for the regulation of axon branching.
Recently, adult dorsal root ganglion axons were also shown to uti-
lize NEDD4 to regulate PTEN during axon growth (Christie et al.,
2012). This work highlights the significance of localized regula-
tion of protein expression and signaling responsiveness of cellular
compartments such as growth cones.
Similarly, dendrites are also affected by loss of PTEN. Most
studies of PTEN deletion in the nervous system that detected
changes in somatic size (see below) also report primary dendrites
of enlarged caliber. A systematic study of the PI3K-Akt-mTOR
signaling cascade in dendrite development found that shRNA
reduction of PTEN resulted in increased branching consistent
with increased activity in this transduction cascade (Jaworski
et al., 2005).
SOMATIC HYPERTROPHY
The importance of themTORC1 signaling pathway and its regula-
tion by PTEN are apparent in the cellular hypertrophy that results
from PTEN loss (Backman et al., 2001). This effect is reversed
in neurons by inhibitors of mTOR kinase activity (Kwon et al.,
2003; Ljungberg et al., 2009; Zhou et al., 2009). Similar hypertro-
phy is also observed in astrocytes (Fraser et al., 2004), but there
is some indication that this phenotype may be sensitive to the
timing of PTEN loss. Embryonic deletion in post-mitotic neu-
rons using NEX1Cre (Kazdoba et al., 2012) as well as DATCre
mice (Diaz-Ruiz et al., 2009; Domanskyi et al., 2011; Inoue et al.,
2013) resulted in somatic hypertrophy, but deletion in mature,
post-natal forebrain neurons using CaMKIIα-Cre did not have
this effect (Sperow et al., 2012). Paralleling this result, virally-
mediated shRNA knock-down of PTEN in adult born dentate
gyrus neurons resulted in somatic hypertrophy, but this effect
is delayed relative to neonatally injected animals (Luikart et al.,
2011). Epistasis experiments pursuing the components of the
pathway responsible for hypertrophy have shown that loss of
the kinase Pdk1 leads to reversal of hypertrophy in GFAPCre;
PTENfl/fl mice (Chalhoub et al., 2009). Loss of S6K1, a key
downstream effector of mTORC1 linking it to protein transla-
tion regulation, did not have the same effect (Chalhoub et al.,
2006). The disruption of the regulated transport of PTEN in
neurons by the motor protein Myosin V has also been shown
to result in somatic hypertrophy (Figure 1) (Van Diepen et al.,
2009). In this case, a direct interaction between these two pro-
teins was shown to exist and to be regulated by either casein
kinase 2 or glycogen synthase kinase 3 beta (GSK3β). These two
studies demonstrate that a number of PTEN regulatory path-
ways can contribute to hypertrophy. An exact delineation of the
mechanisms capable of influencing somatic hypertrophy await
further studies to dissect the individual contributions of each
PTEN regulator.
PTEN AND MYELINATION
An important corollary to PTEN’s effect on neuronal process
outgrowth is the observation of myelination defects following
PTEN loss (Fraser et al., 2008) and the hypermyelination by oligo-
dendrocytes and Schwann cells lacking PTEN following deletion
by oligodendrocyte transcription factor 2 (Olig2)Cre (Harrington
et al., 2010;Maire et al., 2014). 2′, 3′-cyclic nucleotide 3′ phospho-
diesterase (CNP1)Cre or Proteolipid protein 1 (Plp1) ERT2-Cre
(Goebbels et al., 2010). Interestingly, rapamycin treatment of ani-
mals exhibiting altered myelination resulted in amelioration of
the phenotype (Goebbels et al., 2010). This points to the lipid
phosphatase activity of PTEN, and its antagonism of the PI3
kinase/mTOR pathway. A recent report has implicated PTEN as
a key component of the polarized growth and wrapping of the
myelin sheath at its inner tongue via regulation of the maturation
state of the myelinating cell (Snaidero et al., 2014). Conditional
deletion of PTEN using the Plp1-ERT2-Cre line resulted in a
larger inner tongue and more cytoplasmic channels relative to
controls, a sign of less mature myelinating sheets. Cytoplasmic-
rich edges of the sheath in longitudinal sections that were absent
in controls either 23 or 60 days post-natally were also seen
(Goebbels et al., 2010; Snaidero et al., 2014). Deletion of PTEN at
postnatal day 100 led to the reappearance of cytoplasmic myelin
transport channels and increased myelination, relative to controls
(Snaidero et al., 2014). These data indicate that it is possible to
reinitiate the myelination program, even in mature animals, by
increasing PI(3,4,5)P3 levels through loss of PTEN activity. This
establishes PTEN both as a key regulator of embryonic devel-
opment, and as a potential therapeutic target for myelination
disorders and demyelinating diseases.
The profound effect on the inner tongue may be related to
the localization of PTEN within the myelin sheet through inter-
action with scaffolding proteins such as Discs large homology 1
(Dlg1) or PAR-3. Reduction of Dlg1 has been shown to increase
myelination and decrease levels of PTEN, suggesting a reciprocal
stabilizing relationship between these two proteins (Cotter et al.,
2010). However, neither Olig2Cre nor CNP1Cre PTEN cKO mice
exhibit alterations in Dlg1 levels (Maire et al., 2014), (Goebbels
et al., 2010), but there may be small, but significant, changes in
signaling in these mice. Alternatively, the observed hypermyelina-
tion may reflect an alternate PTEN partner since myelination is
also coordinated by a complex of the polarity protein PAR-3 and
the neurotrophin receptor p75NTR (Chan et al., 2006). PTEN
binds PAR-3 (Von Stein et al., 2005; Wu et al., 2007; Feng et al.,
2008), and p75NTR receptor stimulation can increase PTEN
activity (Song et al., 2010), thus it is possible that together as a tri-
partite complex these proteins could regulate axon ensheathment.
However, much like Dlg1, localization of PAR-3 was not altered
in CNP1Cre; PTENflox/flox mice (Goebbels et al., 2012). While the
identity of the molecules targeting PTEN within myelinating cells
may not be resolved, the important role for PTEN/PI3K/mTOR
signaling is clear.
CONCLUSIONS AND FUTURE DIRECTIONS
Since its discovery almost 20 years ago, PTEN has remained a cen-
terpiece of inquiry into signal transduction for a vast array of dis-
ciplines including tumor biology, metabolism, and neuroscience.
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Work over the last decade and a half has significantly strength-
ened our understanding of the major neurodevelopmental roles
for PTEN. Going forward, a clearer understanding of the catalytic
and non-catalytic functions of PTEN during brain development
will be crucial, particularly in terms of transcriptional regulation.
Similarly, the phosphatase activity linked to protein versus lipid
dephosphorylation will expand our compendium of targets regu-
lated by PTEN during nervous system patterning. Systematically
perturbing PTEN interacting partners during brain development
will allow us to begin to form a holistic view of how PTEN loss
leads to the brain phenotypes observed.
It will also be important to develop “next-generation” tools
with which to interrogate PTEN function in the developing brain.
These might include chemical genetic variants of PTEN for rapid
and specific elimination of phosphatase activity either in cell
lines or mouse models, and inducible transgenic lines that per-
mit cell-type specific rescue either with a doxycycline-regulated
system or Cre-induced expression. To define functionality and
understand the consequence of PTEN interacting with binding
partners, point mutant variants should be developed that remove
binding sites for particular partner proteins. Alternatively, sys-
tems can be devised that permit pharmacologic regulation of
PTEN association with partner molecules. Forms of PTEN that
are inducibly targeted to the sub-cellular locales known to be
key sites of action for PTEN would also provide a mechanism
to discern the various roles of PTEN within cellular compart-
ments. Combinations of these and other future technologies
will permit us to further delineate the PTEN-dependent mech-
anisms responsible for sculpting the developing and adult brain.
Furthermore, the continued synergy with other disciplines that
have already contributed significantly to our understanding of
PTEN will continue to shape the field and provide new insights
into PTEN biology enhancing our awareness of the role of PTEN
in the brain.
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